Intellipharmaceutics International Inc. (IPCI)

[no2koolaid]

As I said, all just my opinion. But no business operates without consideration of the external context and, to that end, the socio-political issues cut both ways. How so? Given past accusations of unfair or unequal treatment by the FDA of some pharma firms, the FDA wants to ensure they are creating a level playing field. Ergo, how does one company's BE success for" similar" drugs allow them to bypass an efficacy trial (even granted a 505b2 approach) and another not? In the past, it would. But the FDA has allegedly taken a new approach (supposedly less influenced by certain factions) and it is seeking to be "more fair" not merely expeditious. Again, that is simply my reading. In the near term we will know. But, I think IPCI needs to prepare for that scenario, even if it does not materialize. To not is folly.